Adverse events of COVID-19 vaccines in pregnant and postpartum women in Brazil: A cross-sectional study
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0280284 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift PLOS ONE, 2023. Verfasst von Dimas Tadeu Covas und 5 weiteren Autor:innen. Beteiligte Einrichtung: Butantan Institute, São Paulo, Brazil. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, Vaccines. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sinovac Lifesciences.
Themen: Patientensicherheit
Abstract (Originalsprache)
Background
By the fact that pregnant and postpartum women are currently using COVID-19 vaccines, ensure their safety is critical. So, more safety evidence is crucial to include this new technology to their vaccine’s calendar and to develop public policies regarding the support and training of Health Care Personnel. This study aims to describe the adverse events (AE) of COVID-19 vaccines in pregnant and postpartum women in the early stage of vaccination campaign in Brazil.
Methods
An observational cross-sectional study using data from the Brazilian surveillance information system to characterize the AE of COVID-19 vaccines (Sinovac/Butantan, Pfizer/BioNTech, AstraZeneca and Janssen) in Brazilian pregnant and postpartum women from April to August 2021. Frequency and incidence rate of AE for COVID-19 vaccines were assessed.
Results
3,333 AE following immunization were reported for the study population. AE incidence was 309.4/100,000 doses (95% CI 297.23, 321.51). Within the vaccines available, Sinovac/Butantan had the lowest incidence (74.08/100,000 doses; 95% CI 63.47, 84.69). Systemic events were the most frequent notified (82.07%), followed by local (11.93%) and maternal (4.74%), being most of them classified as non-severe (90.65%).
Conclusion
Our results corroborate the recommendation of vaccination for these groups. Even though, further studies appraising a longer observation time are still needed to provide a broader safety aspect for the vaccines currently under use for this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Butantan Institute, São Paulo, Brazil.
- IQVIA Brazil, São Paulo, Brazil.
ORCID-Profile: Dimas Tadeu Covas
Förderung
- Sinovac Lifesciences
Zitieren
APA
Covas, D. T., de Jesus Lopes de Abreu, A., Zampirolli Dias, C., Vansan Ferreira, R., Gonçalves Pereira, R., & Silva Julian, G. (2023). Adverse events of COVID-19 vaccines in pregnant and postpartum women in Brazil: A cross-sectional study. PLOS ONE. https://doi.org/10.1371/journal.pone.0280284
Vancouver
Covas DT, de Jesus Lopes de Abreu A, Zampirolli Dias C, Vansan Ferreira R, Gonçalves Pereira R, Silva Julian G. Adverse events of COVID-19 vaccines in pregnant and postpartum women in Brazil: A cross-sectional study. PLOS ONE. 2023. doi:10.1371/journal.pone.0280284
BibTeX
@article{Covas2023,
author = {Covas, Dimas Tadeu and de Jesus Lopes de Abreu, Ariane and Zampirolli Dias, Carolina and Vansan Ferreira, Rafaela and Gonçalves Pereira, Ramon and Silva Julian, Guilherme},
title = {Adverse events of COVID-19 vaccines in pregnant and postpartum women in Brazil: A cross-sectional study},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0280284}
}
EUVIMED